We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

14 hedge funds and large institutions have $692K invested in Tenax Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.02% → 0.01% (-0.01%)

33% less funds holding

Funds holding: 21 → 14 (-7)

44% less capital invested

Capital invested by funds: $1.24M → $692K (-$545K)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
14
Holders Change
-7
Holders Change %
-33.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$166K
2
UBS Group
UBS Group
Switzerland
+$22.2K
3
TSS
Two Sigma Securities
New York
+$6.16K
4
HF
HRT Financial
New York
+$1.1K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$334K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$27.5K
3
Millennium Management
Millennium Management
New York
-$13K
4
Renaissance Technologies
Renaissance Technologies
New York
-$10.8K
5
FWP
FAS Wealth Partners
Kansas
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
1
Gofen & Glossberg
Illinois
$424K – – –
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$133K +$166K +756 New
BlackRock
3
BlackRock
New York
$53.4K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$19.4K – – –
UBS Group
5
UBS Group
Switzerland
$17.7K +$22.2K +101 New
State Street
6
State Street
Massachusetts
$15.3K – – –
TSS
7
Two Sigma Securities
New York
$7.54K +$6.16K +28 +200%
Renaissance Technologies
8
Renaissance Technologies
New York
$7K -$10.8K -49 -55%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$6K – – –
Northern Trust
10
Northern Trust
Illinois
$3.86K – – –
HF
11
HRT Financial
New York
$2K +$1.1K +5 +45%
Morgan Stanley
12
Morgan Stanley
New York
$1.51K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$1K – – –
Wells Fargo
14
Wells Fargo
California
$29 – – –
PNC Financial Services Group
15
PNC Financial Services Group
Pennsylvania
$22 -$27.5K -125 Closed
TAM
16
Tucker Asset Management
Colorado
$4 – – –
AC
17
Armistice Capital
New York
– -$334K -1,229 Closed
Millennium Management
18
Millennium Management
New York
– -$13K -49 Closed
FWP
19
FAS Wealth Partners
Kansas
– -$10K -36 Closed
VF
20
Virtu Financial
New York
– -$4K -13 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$3K -12 Closed
CAN
22
Cetera Advisor Networks
California
– -$3K -10 Closed
E
23
Ergoteles
New York
– -$2K -9 Closed
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
– -$2K -6 Closed

TENX Hedge Fund Activity: Q4 2022 in Review

14 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2022, worth a combined $692K — down 44% from $1.24M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TENX and 2 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $166K. The largest seller was Armistice Capital, exiting entirely with an estimated $334K sold.

  • 14 institutional investors held Tenax Therapeutics (TENX) as of Q4 2022, down from 21 in Q3 2022.
  • Funds reported $692K of Tenax Therapeutics stock for Q4 2022, down 44% quarter-over-quarter.
  • 2 funds opened new Tenax Therapeutics positions in Q4 2022 and 9 closed out, a net change of -7 holders.
  • The largest Tenax Therapeutics buyer in Q4 2022 was Acadian Asset Management, an estimated $166K added.
  • The largest Tenax Therapeutics seller in Q4 2022 was Armistice Capital, an estimated $334K sold.

Based on aggregated 13F filings for Q4 2022.